Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine derivatives as active ingredient

The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I) R stands for a C1-6 aliphatic acyl group optionall...

Full description

Saved in:
Bibliographic Details
Main Authors FERENC ANDRASI, SANDOR FARKAS, PAL BERZSENYI
Format Patent
LanguageEnglish
Published 26.08.1998
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I) R stands for a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group, or by one or more halogen(s); or R is a benzoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; or R is absent when a double bond exists between the N(3) and C(4) atoms; R means hydrogen; or R is absent when a double bond exists between the N(3) and C(4) atoms; R means a C1-3 alkyl group; or R and R together stand for a methylene group and no double bond is present between the N(3) and C(4) atoms; R means hydrogen or a C1-4 aliphatic acyl group; R represents hydrogen; a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group or by one or more halogen(s); as well as a benzoyl, palmitoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; and the dotted lines represent valence bonds optionally being present, with the proviso that no double bond exists between the N(3) and C(4) atoms when both R and R stand for hydrogen. The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.
AbstractList The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I) R stands for a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group, or by one or more halogen(s); or R is a benzoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; or R is absent when a double bond exists between the N(3) and C(4) atoms; R means hydrogen; or R is absent when a double bond exists between the N(3) and C(4) atoms; R means a C1-3 alkyl group; or R and R together stand for a methylene group and no double bond is present between the N(3) and C(4) atoms; R means hydrogen or a C1-4 aliphatic acyl group; R represents hydrogen; a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group or by one or more halogen(s); as well as a benzoyl, palmitoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; and the dotted lines represent valence bonds optionally being present, with the proviso that no double bond exists between the N(3) and C(4) atoms when both R and R stand for hydrogen. The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.
Author FERENC ANDRASI
SANDOR FARKAS
PAL BERZSENYI
Author_xml – fullname: FERENC ANDRASI
– fullname: SANDOR FARKAS
– fullname: PAL BERZSENYI
BookMark eNqFjb0KwkAQhK_Qwr9n8B7AK2IqSwmKVbCwl_Wy0YVkd7k7A-bpvYC9w8B8xQyzNDMWxoUZrkE8xmhbCVYDKgTip9UXhB48vhN56KyXXiVSIuHMnIB4atUO_Kdz-13pHsijNAQjKjHaBgMNkGjAaCHbT2jzJmBDyGlt5i10ETe_XJnt-XSrLg5V7hg1XzOme1UXxaHIOpb_G1_cQUcJ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 6
ExternalDocumentID CN1191111A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN1191111A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:25:19 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN1191111A3
Notes Application Number: CN19981003976
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980826&DB=EPODOC&CC=CN&NR=1191111A
ParticipantIDs epo_espacenet_CN1191111A
PublicationCentury 1900
PublicationDate 19980826
PublicationDateYYYYMMDD 1998-08-26
PublicationDate_xml – month: 08
  year: 1998
  text: 19980826
  day: 26
PublicationDecade 1990
PublicationYear 1998
RelatedCompanies GYOGYSZERKUTATO INTEZET K V
RelatedCompanies_xml – name: GYOGYSZERKUTATO INTEZET K V
Score 2.4878902
Snippet The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine derivatives as active ingredient
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19980826&DB=EPODOC&locale=&CC=CN&NR=1191111A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH5BNOpNUYO_ezA72Ti3QXdZjGwQYsIgBg03snUtmJixwMTIX-9r2ZQLyw7LlnVp875-Tfd97wHcPUYN6XDhUiEjmzqMJ9SVjFFpSol0ZVmJ9nH3wmb3zXkZNUYVmJZeGJ0n9FsnR0REccR7rufr7H8TK9DaysVD_IG3Zk-doRcYSWkXQ0ZrGkHLaw_6Qd83fN_zQyN89VQeMzyed2AXF9FMYaH93lKelGyTUDpHsDfAttL8GCoircGBX9Zdq8F-r_jdjZcF8hYnsCwU_QQXmSSbC1U8MJ2QbLq5JU2UQLxQYRElQl-XfyAhjfjPJ7XubRqLdDXDmFiJDD9BEgzApc79vSARnnr2I_jOXCgpWH4Kt5320O9S7MD4b6zGflj21D6DajpLRR2IxHAxGZdu4rgOt1mUIMlHpsWZGVt2wzmH-rZWLrY_uoTDtUEPoda8gmo-_xLXyNB5fKMH9xdQJpnp
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1dT8IwFL1RNOKbogY_6YPZk41zG2wvi5EOggqDGDS8kX20YmLGAhMjv97bsikvLHtYtqxLm3t6mu6cewGu74K6sCLuUC4Ck1p2FFNH2DYVuhBIV4YRKx93z290Xq2nUX20BZPCC6PyhH6r5IiIqAjxnqn5Ov3fxPKUtnJ-G37grel9e-h6WlzYxZDRGprXdFuDvtdnGmMu8zX_xZV5zPB42IYdXGDbEgutt6b0pKTrhNI-gN0BtpVkh7DFkwqUWVF3rQJ7vfx3N17myJsfwSJX9BNcZJJ0xmXxwOSdpJP1LWkiBeK5CotIEfqq_APxaRD9fFLjxqQhT5ZTjIklT_ETJMYAXKjc33MS4KlmP4LvzLiUgmXHUGu3hqxDsQPjv7EaM7_oqXkCpWSa8CoQgeGi25FwYsuxItMOYiT5QDciWw8Ns26dQnVTK2ebH9Wg3Bn2uuPuo_98Dvsrsx7CrnEBpWz2xS-RrbPwSg30L7QKnNw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Process+for+preparing+pharmaceutical+composition+containing+N-acyl-2%2C3-benzodiazepine+derivatives+as+active+ingredient&rft.inventor=FERENC+ANDRASI&rft.inventor=SANDOR+FARKAS&rft.inventor=PAL+BERZSENYI&rft.date=1998-08-26&rft.externalDBID=A&rft.externalDocID=CN1191111A